Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Pathomorphological changes in lung tissue of guinea pigs in SARS-CoV-2 infection model

View through CrossRef
Introduction. The main characteristic of pathogenicity of SARS-CoV-2 virus is its ability to cause death in sensitive laboratory animals. The absence of lethal animal infection models requires the search for other approaches to assess pathogenicity. Studying infectious processes in guinea pig lungs allows us to identify the features and patterns of the disease, determine significant histological characteristics, and identify the main pathogenic criteria. We aimed to conduct a comparative pathomorphological study of lung tissue in guinea pigs infected with various SARS-CoV-2 variants using morphometric standardized criteria. Materials and methods. We looked at structural changes in the lungs of 96 outbred guinea pigs depending on COVID-19 pathogenesis. The animals were randomly divided into seven experimental and one control groups of 6 males and 6 females each. The experimental groups were intranasally infected with the following SARS-CoV-2 strains: Wuhan, Alpha, Beta, Gamma, Delta, and Omicron (the last one represented by two genetic lineages BA.5.2 and EG.5). The control group was intranasally injected with 0.9% NaCl. The viral load over time was determined with RT-PCR on nasal flushes and infection titer (on Vero E6 cell culture). The animals that survived were removed from the experiment on day 15. Pathomorphological examination was performed with optical microscopy of histological lung specimens. Results. We detected diffuse alveolar damage as a similar pathological feature in the lungs of both patients with COVID-19 and guinea pigs. Significant differences were revealed in the number of pathomorphological signs caused by various genetic variants of COVID-19. The most considerable pathological effect of SARS-CoV-2 on lung tissue was caused by the Gamma variant. We suppose guinea pig lung dystelectasis to be the main marker of pathogenicity of SARS-CoV-2 strains, since this sign differs significantly in SARS-CoV-2 variants and is associated with excessive cytokine activity. Alveolar hemorrhagic syndrome is characteristic of all the studied coronavirus variants except for Omicron EG.5. The genetic lineages of the omicron variant have a minimal pathological effect on lung tissue and do not cause death in guinea pigs. Conclusion. Guinea pig is an appropriate animal for a SARS-CoV-2 model. Pathomorphological changes in the lungs depend on the SARS-CoV-2 variant causing them. Keywords: SARS-CoV-2, COVID-19, guinea pig, lungs, pathomorphology, SARS-CoV-2 variants
Title: Pathomorphological changes in lung tissue of guinea pigs in SARS-CoV-2 infection model
Description:
Introduction.
The main characteristic of pathogenicity of SARS-CoV-2 virus is its ability to cause death in sensitive laboratory animals.
The absence of lethal animal infection models requires the search for other approaches to assess pathogenicity.
Studying infectious processes in guinea pig lungs allows us to identify the features and patterns of the disease, determine significant histological characteristics, and identify the main pathogenic criteria.
We aimed to conduct a comparative pathomorphological study of lung tissue in guinea pigs infected with various SARS-CoV-2 variants using morphometric standardized criteria.
Materials and methods.
We looked at structural changes in the lungs of 96 outbred guinea pigs depending on COVID-19 pathogenesis.
The animals were randomly divided into seven experimental and one control groups of 6 males and 6 females each.
The experimental groups were intranasally infected with the following SARS-CoV-2 strains: Wuhan, Alpha, Beta, Gamma, Delta, and Omicron (the last one represented by two genetic lineages BA.
5.
2 and EG.
5).
The control group was intranasally injected with 0.
9% NaCl.
The viral load over time was determined with RT-PCR on nasal flushes and infection titer (on Vero E6 cell culture).
The animals that survived were removed from the experiment on day 15.
Pathomorphological examination was performed with optical microscopy of histological lung specimens.
Results.
We detected diffuse alveolar damage as a similar pathological feature in the lungs of both patients with COVID-19 and guinea pigs.
Significant differences were revealed in the number of pathomorphological signs caused by various genetic variants of COVID-19.
The most considerable pathological effect of SARS-CoV-2 on lung tissue was caused by the Gamma variant.
We suppose guinea pig lung dystelectasis to be the main marker of pathogenicity of SARS-CoV-2 strains, since this sign differs significantly in SARS-CoV-2 variants and is associated with excessive cytokine activity.
Alveolar hemorrhagic syndrome is characteristic of all the studied coronavirus variants except for Omicron EG.
5.
The genetic lineages of the omicron variant have a minimal pathological effect on lung tissue and do not cause death in guinea pigs.
Conclusion.
Guinea pig is an appropriate animal for a SARS-CoV-2 model.
Pathomorphological changes in the lungs depend on the SARS-CoV-2 variant causing them.
Keywords: SARS-CoV-2, COVID-19, guinea pig, lungs, pathomorphology, SARS-CoV-2 variants.

Related Results

From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
AbstractBackgroundSevere acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is an emerging disease with fatal outcomes. In this study, a fundamental knowledge gap question is to...
Performance characteristics of the VIDAS® SARS-COV-2 IgM and IgG serological assays
Performance characteristics of the VIDAS® SARS-COV-2 IgM and IgG serological assays
ABSTRACTThe COVID-19 pandemic, caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread worldwide. Serological testing for SARS-CoV-2-spe...
EPD Electronic Pathogen Detection v1
EPD Electronic Pathogen Detection v1
Electronic pathogen detection (EPD) is a non - invasive, rapid, affordable, point- of- care test, for Covid 19 resulting from infection with SARS-CoV-2 virus. EPD scanning techno...
SARS-CoV-2 within-host diversity of human hosts and its implications for viral immune evasion
SARS-CoV-2 within-host diversity of human hosts and its implications for viral immune evasion
ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is continuously evolving, bringing great challenges to the control of the virus. In the...
Verification of SARS-CoV-2-Encoded small RNAs and contribution to Infection-Associated lung inflammation
Verification of SARS-CoV-2-Encoded small RNAs and contribution to Infection-Associated lung inflammation
AbstractSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes coronavirus disease 2019 (COVID-19), the respiratory illness responsible for the COVID...
SARS-CoV-2 cell-to-cell infection is resistant to neutralizing antibodies
SARS-CoV-2 cell-to-cell infection is resistant to neutralizing antibodies
AbstractThe COVID-19 pandemic caused by SARS-CoV-2 has posed a global threat to human lives and economics. One of the best ways to determine protection against the infection is to ...
The emerging SARS‐CoV‐2 papain‐like protease: Its relationship with recent coronavirus epidemics
The emerging SARS‐CoV‐2 papain‐like protease: Its relationship with recent coronavirus epidemics
AbstractThe papain‐like protease (PLpro) is an important enzyme for coronavirus polyprotein processing, as well as for virus‐host immune suppression. Previous studies reveal that a...
Resistance of endothelial cells to SARS-CoV-2 infectionin vitro
Resistance of endothelial cells to SARS-CoV-2 infectionin vitro
AbstractRationaleThe secondary thrombotic/vascular clinical syndrome of COVID-19 suggests that SARS-CoV-2 infects not only respiratory epithelium but also the endothelium activatin...

Back to Top